Table of Contents
Abstract
The neurogenic bladder Symptom Score (NBSS) is a specialized clinical and research instrument designed to evaluate the severity and impact of lower urinary tract symptoms in individuals with neurogenic bladder dysfunction. Unlike generic urological assessments, which often fail to account for the unique clinical realities of neurological patients (such as the use of intermittent catheterization or the risk of autonomic dysreflexia), the NBSS is tailored specifically to capture the nuanced symptom burden experienced by populations with spinal cord injuries, multiple sclerosis, and similar neurological conditions.
The adaptation of the NBSS into Brazilian Portuguese represents a critical advancement for cross-cultural psychometrics and international urological research. By undergoing a rigorous, standardized translation and cultural adaptation process, the instrument ensures semantic and conceptual equivalence with the original English version. This allows clinicians and researchers in Portuguese-speaking regions to accurately quantify symptom severity, track disease progression, and evaluate the efficacy of therapeutic interventions using a globally recognized metric.
Psychometrically, the Brazilian Portuguese NBSS demonstrates robust reliability and validity, mirroring the performance of the original scale. It provides a multidimensional assessment encompassing incontinence, storage and voiding difficulties, and the broader clinical consequences of neurogenic lower urinary tract dysfunction. By integrating these specific domains with an overarching quality-of-life evaluation, the NBSS serves as an indispensable patient-reported outcome measure that bridges the gap between objective clinical indicators and the subjective patient experience.
📊 Psychometric Scorecard
24
Multidimensional
0.81
📍 Brazil
Authors
Purpose
The primary purpose of the NBSS is to provide a highly specific, patient-reported outcome measure for individuals suffering from neurogenic lower urinary tract dysfunction (NLUTD). Historically, clinicians relied on generic urological questionnaires that were fundamentally ill-suited for neurological patients, as these tools often assume normal physiological voiding and fail to account for alternative bladder management strategies like catheterization. The NBSS fills this critical measurement gap by offering a targeted assessment tool.
The Brazilian Portuguese adaptation of the NBSS specifically addresses the lack of validated, culturally appropriate instruments available for this patient population in Brazil. By providing a reliable tool in the native language, it empowers healthcare professionals to make evidence-based clinical decisions, monitor treatment outcomes accurately, and facilitate the inclusion of Brazilian cohorts in international, multicenter clinical trials.
Construct
The psychological and clinical construct measured by the NBSS is the subjective burden and functional impact of neurogenic lower urinary tract dysfunction. This construct is inherently multidimensional, reflecting the complex interplay between physiological impairment and daily functioning. The scale operationalizes this construct through three primary domains: Incontinence, Storage and Voiding, and Consequences.
The Incontinence domain captures the frequency and severity of involuntary urine loss, while the Storage and Voiding domain assesses the mechanical and sensory difficulties associated with holding and releasing urine. The Consequences domain is particularly unique to the neurogenic population, measuring secondary complications such as urinary tract infections and autonomic dysreflexia. Together with overarching items assessing the method of bladder management and the global impact on Quality of life, these dimensions provide a comprehensive profile of the patient's urological health and its psychosocial toll.
Validity
The validation of the Brazilian Portuguese NBSS involved rigorous assessments of both content and construct validity. Content validity was established through a multidisciplinary expert committee comprising urologists, a urogynecologist, and a physiatrist, who confirmed that the translated items comprehensively and accurately represented the clinical realities of NLUTD.
Construct validity was evaluated using a convergent approach, comparing the NBSS scores with the Qualiveen-SF, another validated measure of urinary-related Quality of life. The analysis revealed a moderate, statistically significant positive correlation (r = 0.66), indicating that the NBSS accurately captures the intended construct of urinary symptom burden. Furthermore, an ANOVA trend analysis demonstrated that patients who self-reported more severe global bladder problems on a Likert scale scored significantly higher on the NBSS, providing strong evidence that the instrument effectively discriminates between varying levels of clinical severity.
Convergent & Discriminant Validation Correlations
| Reference Instrument | Correlation Coefficient (r) |
|---|---|
| Qualiveen-SF | r=0.66 |
Reliability
The reliability of the adapted NBSS was evaluated through measures of internal consistency and temporal stability, both of which yielded strong psychometric results. The internal consistency of the scale was excellent, with a Cronbach's alpha coefficient of 0.81. This value comfortably exceeds the standard threshold of 0.70, indicating that the items within the questionnaire are highly correlated and reliably measure the underlying construct of neurogenic bladder dysfunction without excessive redundancy.
To assess test-retest reliability, the researchers administered the questionnaire to a subset of patients on two separate occasions, 7 to 14 days apart, ensuring no clinical interventions occurred in the interim. The resulting Intraclass Correlation Coefficient (ICC) was 0.86, demonstrating exceptional reproducibility. This high level of temporal stability confirms that the Brazilian Portuguese NBSS is a dependable tool for longitudinal tracking, as it is largely free from random measurement error when the patient's clinical status remains unchanged.
Factor Analysis
In this Cross-cultural adaptation study, the researchers did not conduct a novel exploratory or confirmatory factor analysis to re-evaluate the dimensional structure of the scale. Instead, the psychometric evaluation was grounded in the original conceptual framework established by Welk and colleagues during the initial development of the NBSS.
The original structural model posits a three-factor solution corresponding to the domains of Incontinence, Storage and Voiding, and Consequences. The Brazilian adaptation study implicitly supported this structure by successfully validating the translated instrument as a whole and confirming its internal consistency and construct validity against established measures. Future psychometric investigations within the Brazilian population may benefit from formal structural equation modeling to explicitly confirm the factor loadings and model fit indices of this translated version.
Subscales
| Subscale | Items | Description |
|---|---|---|
| Incontinence | 8 items | Measures the frequency, severity, and specific triggers of involuntary urine leakage. |
| Storage and Voiding | 7 items | Assesses symptoms related to bladder capacity, urgency, and difficulties in emptying the bladder. |
| Consequences | 7 items | Evaluates secondary clinical complications of neurogenic bladder, such as urinary tract infections and autonomic dysreflexia. |
Instrument
| Test Type | Self-report questionnaire |
| Format | 24 items, multiple-choice and Likert-type response formats |
| Scoring | Total score ranges from 0 to 74. Higher scores indicate greater symptom severity and worse outcomes. The first and last questions assess bladder management and overall Quality of life, respectively. |
| Language | Portuguese |
| Population | Clinical patients, Medical patients |
| Age Group | Adults (18 years and older) |
| Administration | Self-administered, with researcher assistance permitted for patients with motor, visual, or cognitive barriers |
Scoring & Interpretation Guidelines
| Normative Reference Values | Median total score = 22 |
Neurogenic Bladder Symptom Score Items
Items are currently not available
The individual items of this scale are not publicly available. Researchers interested in using this instrument should contact the original authors directly to request the scale materials.
Sample
The study included 68 adult patients (57 men and 11 women) with a mean age of 38.9 years. The vast majority of the sample (97.1%) had neurogenic lower urinary tract dysfunction secondary to spinal cord injury. Participants were recruited from daily medical consultation schedules at a specialized clinical facility.
Permissions & Test Year
The cultural adaptation process was carried out after obtaining formal authorization from the original author of the NBSS.
Test Year: 2019
Cite This Paper
Lisley Keller Liidtke Cintra, José de Bessa, Victor Ikky Kawahara, Thereza Phitoe Abe Ferreira, Miguel Srougi, Linamara Rizzo Battistella, Daniel Rúbio de Souza, Homero Bruschini, Cristiano Mendes Gomes (2019). neurogenic bladder Symptom Score. International braz j urol. https://doi.org/10.1590/s1677-5538.ibju.2018.0335
References
30 references
- Clark R (2016). Patient reported outcome measures in neurogenic bladder. Transl Androl Urol, 5 22.
- Narang GL (2017). patient-reported outcome measures in urology. Curr Opin Urol, 27 366. 🔗 https://doi.org/10.1097/MOU.0000000000000412
- McKenna SP (2011). Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med, 9 86. 🔗 https://doi.org/10.1186/1741-7015-9-86
- Tamanini JT (2004). Concurrent validity, internal consistency and responsiveness of the Portuguese version of the King's Health Questionnaire (KHQ) in women after stress urinary incontinence surgery. Int Braz J Urol, 30 479. 🔗 https://doi.org/10.1590/S1677-55382004000600005
- Barry MJ (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol, 148 1549. 🔗 https://doi.org/10.1016/S0022-5347(17)36966-5
- Costa P (2001). Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol, 39 107. 🔗 https://doi.org/10.1159/000052421
- Bonniaud V (2006). Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis. Arch Phys Med Rehabil, 87 1661. 🔗 https://doi.org/10.1016/j.apmr.2006.08.345
- Welk B (2013). The conceptualization and development of a patient-reported neurogenic bladder symptom score. Res Rep Urol, 5 129.
- Guillemin F (1995). Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol, 24 61. 🔗 https://doi.org/10.3109/03009749509099285
- Beaton DE (2000). Guidelines for the process of Cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976), 25 3186. 🔗 https://doi.org/10.1097/00007632-200012150-00014
- Welk B (2014). The validity and reliability of the neurogenic bladder symptom score. J Urol, 192 452. 🔗 https://doi.org/10.1016/j.juro.2014.01.027
- Keszei AP (2010). Introduction to health measurement scales. J Psychosom Res, 68 319. 🔗 https://doi.org/10.1016/j.jpsychores.2010.01.006
- Nader BB (2016).
- D’Ancona CA (2009). Quality of life of neurogenic patients: translation and validation of the Portuguese version of Qualiveen. Int Urol Nephrol, 41 29. 🔗 https://doi.org/10.1007/s11255-008-9402-3
- Mokkink LB (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol, 63 737. 🔗 https://doi.org/10.1016/j.jclinepi.2010.02.006
- Rumsey DJ (2011). 384.
- Fachel J CS (2000). Avaliação psicométrica: a qualidade das medidas e o entendimento dos dados.
- Streiner DL NG (1995).
- Calado AA (2010). Cross-cultural adaptation of the dysfunctional voiding score sympto (DVSS) questionnaire for Brazilian children. Int Braz J Urol, 36 458. 🔗 https://doi.org/10.1590/S1677-55382010000400009
- Guillemin F (1993). Cross-cultural adaptation of health-related Quality of life measures: literature review and proposed guidelines. J Clin Epidemiol, 46 1417. 🔗 https://doi.org/10.1016/0895-4356(93)90142-N
- Welk B (2017). A pilot study of the responsiveness of the neurogenic bladder Symptom Score (NBSS). Can Urol Assoc J, 11 376. 🔗 https://doi.org/10.5489/cuaj.4833
- Fragalà E (2015). Association Between the neurogenic bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction. Int Neurourol J, 19 272. 🔗 https://doi.org/10.5213/inj.2015.19.4.272
- Tamanini JT (2004). Validation of the “International Consultation on Incontinence Questionnaire –Short Form” (ICIQ-SF) for Portuguese. Rev Saude Publica, 38 438. 🔗 https://doi.org/10.1590/S0034-89102004000300015
- OUZA CCdCe (2010).
- Leeuw Ed. (2001). Reducing missing data in surveys: An overview of methods. Quality and Quantity, 35 (2), 147. 🔗 https://doi.org/10.1023/A:1010395805406
- van Nispen RM (2010). Vision-related Quality of life Core Measure (VCM1) showed low-impact differential item functioning between groups with different administration modes. J Clin Epidemiol, 63 1232. 🔗 https://doi.org/10.1016/j.jclinepi.2009.12.010
- Terwee CB (2007). Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 60 34. 🔗 https://doi.org/10.1016/j.jclinepi.2006.03.012
- Anthoine E (2014). Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes, 12 176. 🔗 https://doi.org/10.1186/s12955-014-0176-2
- Danielsen AK (2015). Translation of questionnaires measuring health related Quality of life is not standardized: a literature based research study. PLoS One, 10 🔗 https://doi.org/10.1371/journal.pone.0127050
- Bellucci CH (2015). Contemporary trends in the epidemiology of traumatic spinal cord injury: changes in age and etiology. Neuroepidemiology, 44 85. 🔗 https://doi.org/10.1159/000371519
Cite this article
Mohammed looti (2026). Neurogenic Bladder Symptom Score. PSYCHOLOGICAL SCALES. Retrieved from https://scales.arabpsychology.com/s/neurogenic-bladder-symptom-score/
Mohammed looti. "Neurogenic Bladder Symptom Score." PSYCHOLOGICAL SCALES, 14 Aug. 2026, https://scales.arabpsychology.com/s/neurogenic-bladder-symptom-score/.
Mohammed looti. "Neurogenic Bladder Symptom Score." PSYCHOLOGICAL SCALES, 2026. https://scales.arabpsychology.com/s/neurogenic-bladder-symptom-score/.
Mohammed looti (2026) 'Neurogenic Bladder Symptom Score', PSYCHOLOGICAL SCALES. Available at: https://scales.arabpsychology.com/s/neurogenic-bladder-symptom-score/.
[1] Mohammed looti, "Neurogenic Bladder Symptom Score," PSYCHOLOGICAL SCALES, vol. X, no. Y, ص Z-Z, August, 2026.
Mohammed looti. Neurogenic Bladder Symptom Score. PSYCHOLOGICAL SCALES. 2026;vol(issue):pages.